Back to top
more

Diversified Healthcare Trust (DHC)

(Delayed Data from NSDQ)

$2.36 USD

2.36
761,883

0.00 (0.00%)

Updated May 1, 2024 04:00 PM ET

After-Market: $2.35 -0.01 (-0.42%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 251)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Diversified Healthcare (DHC) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of -275% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Capstar Financial (CSTR) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Capstar Financial (CSTR) delivered earnings and revenue surprises of 9.80% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Diversified Healthcare (DHC) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of -233.33% and -1.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Ventas (VTR) This Earnings Season?

by Zacks Equity Research

While Ventas (VTR) is well poised to bank on the senior housing industry's recovery that is likely to have aided it in Q2, disposition of assets and higher expenses might have been deterrents.

Diversified Healthcare (DHC) Tops Q2 FFO Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of 150.00% and -6.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Is Diversified Healthcare (DHC) a Great Stock for Value Investors?

by Zacks Equity Research

Is Diversified Healthcare (DHC) a great pick from the value investor's perspective right now? Read on to know more.

Diversified Healthcare (DHC) Misses Q1 FFO and Revenue Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of -33.33% and -0.27%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Ventas (VTR) to Post Q1 Earnings: What's in the Offing?

by Zacks Equity Research

While the gradual rebound in clinical activity is expected to have supported Ventas' (VTR) office segment performance, the pandemic-led concerns continued to be setbacks for its seniors housing business.

Is Recovery in the Cards for Welltower (WELL) in Q1 Earnings?

by Zacks Equity Research

Despite increased coverage of vaccine administration among senior housing residents, Welltower (WELL) witnesses a significant occupancy decline at its senior housing operating portfolio in Q1.

Life-Science Assets to Aid Ventas (VTR) Amid Pandemic Woes

by Zacks Equity Research

Amid the COVID-19 outbreak, which is taking a toll on Ventas' (VTR) senior housing operations, the company is attuning its portfolio with higher exposure to resilient office segment assets.

Welltower (WELL) Expects 1Q21 FFO to Reach Top-End of Outlook

by Zacks Equity Research

Backed by a rise in vaccination coverage, the removal of admission bans and a spike in move-ins, Welltower's (WELL) seniors housing occupancy decline moderated in March. This will aid Q1 results.

New Strong Sell Stocks for January 26th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Welltower's (WELL) Seniors Housing Occupancy Slip Continues in Q4

by Zacks Equity Research

While vaccinations renew hope for Welltower's (WELL) seniors housing portfolio, occupancy declines and seasonal move-outs continue to plague its performance.

Diversified Healthcare (DHC) Q3 FFO and Revenues Miss Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of -50.00% and -0.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Top Ranked Value Stocks to Buy for October 26th

by Zacks Equity Research

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 26th.

Top Ranked Value Stocks to Buy for October 23rd

by Zacks Equity Research

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 23rd.

Top Ranked Value Stocks to Buy for October 22nd

by Zacks Equity Research

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 22nd

DHC vs. PEAK: Which Stock Is the Better Value Option?

by Zacks Equity Research

DHC vs. PEAK: Which Stock Is the Better Value Option?

Diversified Healthcare (DHC) Q2 FFO and Revenues Top Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of 50.00% and 0.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Implied Volatility Surging for Diversified Healthcare Trust (DHC) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Diversified Healthcare Trust (DHC) stock based on the movements in the options market lately.

Diversified Healthcare (DHC) Q1 FFO and Revenues Top Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of 3.57% and 1.15%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Diversified Healthcare (DHC) Q4 FFO Meet Estimates

by Zacks Equity Research

Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0.00% and 1.10%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Top Ranked Income Stocks to Buy for February 20th

by Zacks Equity Research

Here are four stocks with buy rank and strong income characteristics for investors to consider today, February 20th

DHC or VTR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

DHC vs. VTR: Which Stock Is the Better Value Option?

Top Ranked Income Stocks to Buy for January 22nd

by Zacks Equity Research

Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 22nd